This page lists studies registered on ClinicalTrials.gov that name the compounds below among their listed interventions. Titles, phases, status, sponsors, dates, locations, and enrollment figures are taken from the official registry records. It is a research reference only. It is not medical advice, and it does not offer or recommend any product for human or veterinary use.
No registered studies match that search or filter.
Not yet recruitingNot applicableSemaglutide
- NCT ID
- NCT07586150
- Sponsor
- Ludwig-Maximilians - University of Munich
- Registry dates
- 2028-10 – 2030-12
- Enrollment
- 140 registered participants
- Locations
- Austria, Germany, Netherlands
- Conditions listed
- Severe Mental Illness; Depression / Major Depressive Disorder; Bipolar Disorder (BD); Schizophrenia
Registry record on ClinicalTrials.gov
Not yet recruitingNot applicableThymosin Alpha-1
- NCT ID
- NCT07382375
- Sponsor
- Nanjing Medical University
- Registry dates
- 2027-12-31 – 2027-12-31
- Enrollment
- 300 registered participants
- Locations
- China
- Conditions listed
- Aortic Aneurysm and Dissection
Registry record on ClinicalTrials.gov
Not yet recruitingNot applicableTirzepatide
- NCT ID
- NCT07728318
- Sponsor
- Akhtar Saeed Medical and Dental College
- Registry dates
- 2027-12-12 – 2028-05-12
- Enrollment
- 52 registered participants
- Conditions listed
- Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 2Semaglutide
- NCT ID
- NCT07430332
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Registry dates
- 2027-09-01 – 2030-01-01
- Enrollment
- 15 registered participants
- Locations
- United States
- Conditions listed
- Stage 1 Diabetes Mellitus, Type 1
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 2, Phase 3Semaglutide
- NCT ID
- NCT07797036
- Sponsor
- University of Massachusetts, Worcester
- Registry dates
- 2027-09-01 – 2030-12-31
- Enrollment
- 226 registered participants
- Locations
- United States
- Conditions listed
- Gestational Diabetes Mellitus (GDM); Metabolic Syndrome
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 2Methylene Blue
- NCT ID
- NCT06052956
- Sponsor
- University of Rochester
- Registry dates
- 2027-07-15 – 2032-06-30
- Enrollment
- 120 registered participants
- Locations
- United States
- Conditions listed
- Abscess
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 2Methylene Blue
- NCT ID
- NCT07179003
- Sponsor
- University of Rochester
- Registry dates
- 2027-07 – 2032-06
- Enrollment
- 50 registered participants
- Locations
- United States
- Conditions listed
- Breast Abscess
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 1, Phase 2Teriparatide
- NCT ID
- NCT06303284
- Sponsor
- University of Calgary
- Registry dates
- 2027-03-15 – 2031-03-17
- Enrollment
- 54 registered participants
- Locations
- Canada
- Conditions listed
- Lower Extremity Fractures; Pelvis; Acetabulum
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 2Tirzepatide
- NCT ID
- NCT07265752
- Sponsor
- Brigham and Women's Hospital
- Registry dates
- 2027-03-01 – 2028-06-30
- Enrollment
- 6 registered participants
- Conditions listed
- Cannabis Use Disorder
Registry record on ClinicalTrials.gov
Not yet recruitingObservationalTirzepatide
- NCT ID
- NCT07847515
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Registry dates
- 2027-02-01 – 2027-07-01
- Enrollment
- 80 registered participants
- Locations
- China
- Conditions listed
- Obesity / Overweight
Registry record on ClinicalTrials.gov
Not yet recruitingObservationalSemaglutide
- NCT ID
- NCT05714683
- Sponsor
- Novo Nordisk A/S
- Registry dates
- 2027-01-31 – 2027-10-31
- Enrollment
- 600 registered participants
- Conditions listed
- Diabetes Mellitus, Type 2
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 2Testagen
- NCT ID
- NCT02733133
- Sponsor
- Transdermal Delivery Solutions Corp
- Registry dates
- 2027-01-05 – 2027-12
- Enrollment
- 96 registered participants
- Conditions listed
- Hypogonadotropism
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 1HGH
- NCT ID
- NCT06558422
- Sponsor
- Columbia University
- Registry dates
- 2027-01-01 – 2029-02-28
- Enrollment
- 36 registered participants
- Locations
- United States
- Conditions listed
- Insulin Resistance; Hyperinsulinemia; Metabolic Dysfunction Associated Steatotic Liver Disease; Non-Alcoholic Fatty Liver Disease +2 more
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 3Melatonin
- NCT ID
- NCT07418554
- Sponsor
- University Hospital, Strasbourg, France
- Registry dates
- 2027-01-01 – 2029-06-01
- Enrollment
- 120 registered participants
- Locations
- France
- Conditions listed
- Post-traumatic Stress Disorder (PTSD); Current Significant Sleep Disturbances
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 2Semaglutide
- NCT ID
- NCT07614412
- Sponsor
- Ministry of Health, Saudi Arabia
- Registry dates
- 2027-01-01 – 2028-12-31
- Enrollment
- 240 registered participants
- Locations
- Saudi Arabia
- Conditions listed
- Type 1 Diabetes Mellitus
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 1Hyaluronic Acid
- NCT ID
- NCT07662226
- Sponsor
- Cairo University
- Registry dates
- 2027-01-01 – 2027-07-01
- Enrollment
- 24 registered participants
- Locations
- Egypt
- Conditions listed
- Plaque Induced Gingival Disease
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 1BPC-157
- NCT ID
- NCT07803250
- Sponsor
- University of Arkansas
- Registry dates
- 2027-01-01 – 2027-08-01
- Enrollment
- 30 registered participants
- Locations
- United States
- Conditions listed
- Rotator Cuff Tear
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 2Semaglutide
- NCT ID
- NCT07820358
- Sponsor
- The Methodist Hospital Research Institute
- Registry dates
- 2027-01-01 – 2031-12-31
- Enrollment
- 48 registered participants
- Locations
- United States
- Conditions listed
- Endometrial Atypical Hyperplasia; Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia; Endometrial Cancer Stage I; Endometrial Cancer +2 more
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 4Semaglutide
- NCT ID
- NCT07858331
- Sponsor
- Kristin Clemens
- Registry dates
- 2027-01-01 – 2029-01-01
- Enrollment
- 880 registered participants
- Locations
- Canada
- Conditions listed
- Obesity; Chronic Kidney Disease; Chronic Renal Disease; CKD
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 2Tirzepatide
- NCT ID
- NCT07078838
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Registry dates
- 2027-01 – 2029-03
- Enrollment
- 40 registered participants
- Locations
- United States
- Conditions listed
- Endometrial Cancer; Endometrial Intraepithelial Neoplasia; Grade 1 Endometrial Endometrioid Carcinoma
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 2Botulinum Toxin
- NCT ID
- NCT07624045
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Registry dates
- 2027-01 – 2029-07
- Enrollment
- 108 registered participants
- Locations
- France
- Conditions listed
- Piriformis Muscle Syndrome
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 3Tirzepatide
- NCT ID
- NCT07829198
- Sponsor
- Universidade do Porto
- Registry dates
- 2027-01 – 2028-12
- Enrollment
- 70 registered participants
- Locations
- Portugal
- Conditions listed
- Obesity
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 3Vitamin B12
- NCT ID
- NCT06966856
- Sponsor
- Tanta University
- Registry dates
- 2026-12-30 – 2029-12-30
- Enrollment
- 23 registered participants
- Conditions listed
- Hypovitaminosis b 12
Registry record on ClinicalTrials.gov
RecruitingPhase 2Oxytocin
- NCT ID
- NCT06364228
- Sponsor
- University of Nebraska
- Registry dates
- 2026-12-20 – 2028-03
- Enrollment
- 32 registered participants
- Locations
- United States
- Conditions listed
- Stress
Registry record on ClinicalTrials.gov
Not yet recruitingPhase 2, Phase 3Semaglutide
- NCT ID
- NCT06913023
- Sponsor
- University Health Network, Toronto
- Registry dates
- 2026-12-05 – 2029-12-30
- Enrollment
- 37 registered participants
- Locations
- Canada
- Conditions listed
- Kidney Transplant Recipient
Registry record on ClinicalTrials.gov